Xiaoan Wei

Sir Run Run Shaw Hospital
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction: Site-1 protease controls osteoclastogenesis by mediating LC3 transcription.

Correction: Site-1 protease controls osteoclastogenesis by mediating LC3 transcription.

Journal: Cell death and differentiation

Published: February 24, 2026

THBS1+ Macrophages Exacerbate Modic Changes via SDC4-Dependent Activation of NLRP3 Inflammasome.

THBS1+ Macrophages Exacerbate Modic Changes via SDC4-Dependent Activation of NLRP3 Inflammasome.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 19, 2026

S1P regulates intervertebral disc aging by mediating endoplasmic reticulum-mitochondrial calcium ion homeostasis.

S1P regulates intervertebral disc aging by mediating endoplasmic reticulum-mitochondrial calcium ion homeostasis.

Journal: JCI insight

Published: November 21, 2023

In vivo therapy of osteosarcoma using anion transporters-based supramolecular drugs.

In vivo therapy of osteosarcoma using anion transporters-based supramolecular drugs.

Journal: Journal of nanobiotechnology

Published: September 27, 2023

Mrgprb2-mediated mast cell activation exacerbates Modic changes by regulating immune niches.

Mrgprb2-mediated mast cell activation exacerbates Modic changes by regulating immune niches.

Journal: Experimental & molecular medicine

Published: August 31, 2023

A Dual-Targeted Metal-Organic Framework Based Nanoplatform for the Treatment of Rheumatoid Arthritis by Restoring the Macrophage Niche.

A Dual-Targeted Metal-Organic Framework Based Nanoplatform for the Treatment of Rheumatoid Arthritis by Restoring the Macrophage Niche.

Journal: ACS nano

Published: July 10, 2023

The deubiquitinase UCHL1 negatively controls osteoclastogenesis by regulating TAZ/NFATC1 signalling.

The deubiquitinase UCHL1 negatively controls osteoclastogenesis by regulating TAZ/NFATC1 signalling.

Journal: International journal of biological sciences

Published: December 25, 2022

Methyl 3,4-dihydroxybenzoate inhibits RANKL-induced osteoclastogenesis via Nrf2 signaling in vitro and suppresses LPS-induced osteolysis and ovariectomy-induced osteoporosis in vivo.

Methyl 3,4-dihydroxybenzoate inhibits RANKL-induced osteoclastogenesis via Nrf2 signaling in vitro and suppresses LPS-induced osteolysis and ovariectomy-induced osteoporosis in vivo.

Journal: Acta biochimica et biophysica Sinica

Published: August 05, 2022

Sigma-1 receptor attenuates osteoclastogenesis by promoting ER-associated degradation of SERCA2.

Sigma-1 receptor attenuates osteoclastogenesis by promoting ER-associated degradation of SERCA2.

Journal: EMBO molecular medicine

Published: November 03, 2021

Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-κB/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis.

Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-κB/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis.

Journal: Clinical and translational medicine

Published: April 30, 2021

Site-1 protease controls osteoclastogenesis by mediating LC3 transcription.

Site-1 protease controls osteoclastogenesis by mediating LC3 transcription.

Journal: Cell death and differentiation

Published: June 29, 2020

Damage to the human lumbar cartilage endplate and its clinical implications.

Damage to the human lumbar cartilage endplate and its clinical implications.

Journal: Journal of anatomy

Published: June 27, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026